High-Amplitude Functional Exercises in Older Adults With Mild Cognitive Impairment
9 de agosto de 2026 actualizado por: Yunus Emre Tutuneken, Istinye University
Effects of Dual-Task-Based High-Amplitude Functional Exercises on Balance and Functional Mobility in Older Adults With Mild Cognitive Impairment
This study will investigate the effects of dual-task-based high-amplitude functional exercises on balance and functional mobility in older adults with mild cognitive impairment.
A total of 36 participants aged 65 years and older will be randomly assigned to either a high-amplitude functional exercise group or a traditional balance and mobility exercise group.
Both groups will participate in exercise sessions four times per week for four weeks, with each session lasting 60 minutes.
The effects of the exercise programs will be evaluated by assessing balance, functional mobility, dual-task performance, walking performance, fear of falling, and independence in daily activities before and after the intervention.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Tipo de estudio
Intervencionista
Inscripción (Estimado)
36
Fase
- No aplica
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto Mayor
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Living independently/actively in a nursing home.
- Diagnosis of Mild Cognitive Impairment (MCI) based on a standardized screening test, with a Montreal Cognitive Assessment (MoCA) score of 18-25.
- Ability to walk independently for at least 10 meters without an assistive device or with only a cane/single-point support.
- Sufficient vision and hearing capacity to follow dual-task instructions and exercise directions, which may be corrected with glasses or hearing aids.
- Stable medical condition that does not prevent participation in the exercise program throughout the study.
Exclusion Criteria:
- Diagnosis of dementia or severe cognitive impairment based on cognitive screening (MoCA <17).
- Neurological conditions that primarily affect balance, such as Parkinson's disease, residual effects of stroke, multiple sclerosis, or cerebellar ataxia.
- Severe osteoarthritis, active inflammatory joint disease, or a history of major orthopedic surgery within the previous 6 months that could limit exercise performance.
- Uncontrolled hypertension, heart failure (NYHA Class III-IV), or cardiopulmonary instability causing symptoms during exercise.
- Advanced vestibular pathology or severe loss of proprioception in the lower extremities that could be the primary cause of balance impairment.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Dual-Task-Based High-Amplitude Functional Exercise
|
Participants will receive a dual-task-based high-amplitude functional exercise program consisting of high-amplitude functional movements combined with progressively challenging cognitive tasks.
The program will be administered 4 times per week for 4 weeks, for a total of 16 sessions, with each session lasting 60 minutes.
Exercise intensity will be prescribed as maximal effort, corresponding to 7-8/10 on the Borg Rating of Perceived Exertion Scale.
The program will include seated and standing functional exercises, large-amplitude stepping movements, dynamic movements, large-amplitude walking, functional task activities, and complex functional tasks.
|
|
Comparador activo: Traditional Balance and Mobility Exercise
|
Participants will receive a traditional balance and mobility exercise program administered 4 times per week for 4 weeks, for a total of 16 sessions, with each session lasting 60 minutes.
Exercise intensity will be moderate, corresponding to 4-5/10 on the Borg Rating of Perceived Exertion Scale.
The program will consist of motor tasks without cognitive dual-task components.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Dual-Task Timed Up and Go Test
Periodo de tiempo: Baseline to post-intervention (4 weeks)
|
The Dual-Task TUG will assess functional mobility under cognitive load by adding a cognitive task to the standard Timed Up and Go test.
Test performance will be recorded as the time required to complete the task.
|
Baseline to post-intervention (4 weeks)
|
|
Mini-BESTest
Periodo de tiempo: Baseline to post-intervention (4 weeks)
|
The Mini-BESTest will be used to assess balance performance across anticipatory postural control, reactive postural control, sensory orientation, and dynamic gait.
The scale consists of 14 items scored from 0 to 2, with a maximum total score of 28.
Higher scores indicate better balance performance.
|
Baseline to post-intervention (4 weeks)
|
|
Five Times Sit-to-Stand Test
Periodo de tiempo: Baseline to post-intervention (4 weeks)
|
The Five Times Sit-to-Stand Test will be used to assess lower-extremity muscle strength and functional capacity.
The time required to complete five full sit-to-stand repetitions will be recorded.
|
Baseline to post-intervention (4 weeks)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Timed Up and Go Test (TUG)
Periodo de tiempo: Baseline to post-intervention (4 weeks)
|
The TUG will be used to assess functional mobility and dynamic balance.
|
Baseline to post-intervention (4 weeks)
|
|
Edinburgh Visual Gait Score
Periodo de tiempo: Baseline to post-intervention (4 weeks)
|
The EVGS will be used to assess gait quality through observational analysis of gait kinematics across different anatomical segments.
|
Baseline to post-intervention (4 weeks)
|
|
Dual-Task Walking Speed
Periodo de tiempo: Baseline to post-intervention (4 weeks)
|
Walking speed will be measured during a cognitive dual-task condition over a 10-meter walking course and recorded in meters per second.
|
Baseline to post-intervention (4 weeks)
|
|
Dual-Task Cost
Periodo de tiempo: Baseline to post-intervention (4 weeks)
|
Dual-task cost will be calculated from the TUG performance using the formula.
|
Baseline to post-intervention (4 weeks)
|
|
Falls Efficacy Scale-International I
Periodo de tiempo: Baseline to post-intervention (4 weeks)
|
The FES-I will be used to assess concerns about falling during daily activities.
Higher scores indicate greater fear of falling.
|
Baseline to post-intervention (4 weeks)
|
|
Barthel Index
Periodo de tiempo: Baseline to post-intervention (4 weeks)
|
The Barthel Index will be used to assess independence in basic activities of daily living, including eating, bathing, dressing, and transfers.
Scores range from 0 to 100, with higher scores indicating greater independence.
|
Baseline to post-intervention (4 weeks)
|
|
Global Change Scale
Periodo de tiempo: Post-intervention (4 weeks)
|
The Global Change Scale will be used to assess participants' perceived change following the intervention.
Participants will rate perceived change from -5 (much worse) to +5 (much better).
|
Post-intervention (4 weeks)
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
20 de agosto de 2026
Finalización primaria (Estimado)
5 de abril de 2027
Finalización del estudio (Estimado)
5 de abril de 2027
Fechas de registro del estudio
Enviado por primera vez
9 de agosto de 2026
Primero enviado que cumplió con los criterios de control de calidad
9 de agosto de 2026
Publicado por primera vez (Actual)
13 de agosto de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
13 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
9 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 104
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .